CPT 3050F LDL‑C ≥130 mg/dL Reimbursement

CPT code 3050F denotes a documented LDL-C (low density lipoprotein cholesterol) value of greater than or equal to 130 mg/dL. This measure captures an elevated LDL-C result used by clinicians to evaluate a patient’s risk for coronary artery disease and related metabolic conditions, and it can influence medication management for cholesterol or diabetes. Nationally, LDL-C measurement is a core laboratory marker in preventive cardiometabolic care and quality measurement programs, making documentation of elevated values relevant for clinical decision-making and quality reporting.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise description of what CPT code 3050F represents, the typical clinical setting and service type, and the policy and billing context that affects how elevated LDL-C results are recorded and reported. The publication summarizes clinical context, common billing modifiers and practical considerations for documenting the measure. If specific operational details such as associated taxonomies, ICD-10 diagnoses, or related codes are not provided in the source, the report notes data not available in the input and focuses on the available clinical and billing description.

Billing Code Overview

CPT code 3050F represents a laboratory measure for low density lipoprotein cholesterol (LDL-C) where the most recent recorded LDL-C level is greater than or equal to 130 mg/dL. The test is part of a lipid profile used to assess cholesterol levels and inform clinical decisions about cardiovascular and metabolic risk.

Service type: Laboratory test—lipid panel component (LDL-C)

Typical site of service: Outpatient laboratory, clinic, or hospital outpatient department, where blood draws and routine lipid testing are performed.

Clinical Context

A 58-year-old patient with a history of hyperlipidemia and type 2 diabetes presents for routine chronic disease management. The primary care provider orders a lipid panel including an LDL-C measurement during a scheduled clinic visit to assess cardiovascular risk and guide lipid-lowering therapy adjustments. A phlebotomy technician draws blood in the outpatient clinic; the specimen is processed in the outpatient laboratory and results are reviewed by the provider within days. The most recent LDL-C result is >= 130 mg/dL, indicating elevated LDL-C. The provider documents the elevated LDL-C value, evaluates medication adherence and side effects, and considers therapy intensification or lifestyle counseling as part of the visit note. Typical sites of service include the outpatient physician office and outpatient laboratory collection sites.

Coding Specifications

Modifier	Description	When to Use
`00`	Service not otherwise specified by a more specific modifier	Use as a general default when no other modifier applies.
`GC`	Service delivered with resident physician involvement under a teaching physician’s direction

Taxonomy Code	Specialty	Notes
207Q00000X	Family Medicine	Primary care physicians commonly order and manage lipid testing and therapy.
207R00000X	Internal Medicine	Internists manage chronic hyperlipidemia and interpret LDL-C results.
207RC0000X	Endocrinology	Endocrinologists often manage dyslipidemia in patients with diabetes.
2085R0200X	Clinical Pathology/Laboratory	Laboratory physicians oversee test performance, quality, and reporting.
207L00000X	Cardiovascular Disease	Cardiologists use LDL-C to risk-stratify and manage coronary artery disease risk.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E78.5`	Hyperlipidemia, unspecified	Primary indication for LDL-C testing to assess and manage elevated cholesterol.
`E78.0`	Pure hypercholesterolemia	Directly related to elevated LDL-C levels and guides lipid-lowering therapy.
`E11.9`	Type 2 diabetes mellitus without complications	Diabetes increases cardiovascular risk; LDL-C monitoring informs risk reduction strategies.
`I10`	Essential (primary) hypertension	Hypertension commonly coexists with dyslipidemia and influences cardiovascular risk assessment.
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Patients with known coronary disease require LDL-C monitoring to guide secondary prevention.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80061`	Lipid panel; total cholesterol, HDL cholesterol, and triglycerides, and calculation of LDL-cholesterol	Often ordered alongside or instead of a standalone LDL-C to provide full lipid profile for risk assessment.
`82465`	Cholesterol, LDL (direct measurement)	Direct LDL-C assay sometimes used when calculated LDL is unreliable (e.g., high triglycerides) and may be ordered after an elevated screening result.
`36415`	Collection of venous blood by venipuncture	Phlebotomy procedure performed to obtain the specimen for LDL-C testing.
`99000`	Handling and/or conveyance of specimen to laboratory	Ancillary charge sometimes used for specimen handling logistics in outpatient settings.
`99213`	Office/outpatient visit for evaluation and management of an established patient, typically 15 minutes	Common E/M level used when the provider documents review of LDL-C results and medication management in the same visit.

OpenPayer

Summary & Overview

CPT 3050F: LDL-C Level ≥130 mg/dL